Once a case settles, class members typically need to fill out and file a claim form online or by mail by the settlement deadline to receive a share of the settlement money or, in certain cases, settlement rebates or coupons. Drug and medical device companies are responsible for delivering safe products and for warning about potential risks. But manufacturer negligence and flaws in the U.S. Food and Drug Administration’s approval process may put millions at risk of serious, debilitating injuries — including death. Neurontin (gabapentin) lawsuits center around severe skin reactions including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Plaintiffs allege that Pfizer failed to adequately warn patients and doctors about these potentially life-threatening risks. Neurontin (generic name: gabapentin) was FDA-approved in 1993 for use as an anticonvulsant for people suffering from partial seizures associated with epilepsy. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. Discussion of the legal issues You should use this form if you are an eligible class member who has purchased Neurontin or generic gabapentin during the class period. It is required for claiming your portion of the settlement fund successfully. Federal prosecutors on Thursday announced that Pfizer has agreed to plead guilty to criminal wrongdoing and pay a settlement of $430 million in a whistleblower lawsuit alleging that the Parke-Davis unit of Pfizer subsidiary Warner-Lambert illegally encouraged physicians to prescribe the epilepsy drug Neurontin to treat conditions other than those approved by FDA, <i>USA Today</i> reports. Hello: There was a class action involving this drug, and that class action was settled several years ago. The manufacturers of the drug Neurontin reached a $325 million class action lawsuit settlement Wednesday over allegations they fraudulently marketed the prescription drug, which is used to treat seizures, restless leg syndrome, and pain caused by shingles. A Gabapentin lawsuit was filed in 2022, alleging that the manufacturers of Gabapentin failed to warn patients about the potential side effects of the medication, particularly memory loss. However, the overall benefits of Gabapentin in treating various conditions cannot be overlooked. The Neurontin settlement marks the end to a nearly 10-year-old class action lawsuit battle in which plaintiffs, who included both direct purchasers and third-party payers, accused Pfizer of delaying generic versions of Neurontin and promoted the drug for unapproved uses. Find no proof required class action settlements, rebates, and coupons. File claims you may qualify for to get paid out! Sign Up For Our Newsletter! Note: Class action claims are submitted under penalty of perjury - Do not submit fraudulent claims. WASHINGTON, D.C. – The U.S. Drug Enforcement Administration (DEA) and the U.S. Food and Drug Administration (FDA) should promptly classify the markedly overprescribed seizure and neuropathic pain drug gabapentin and the closely related drug gabapentin enacarbil as schedule V controlled substances, because they are increasingly being misused, abused, and diverted, leading to dependence and Gabapentin may cause side effects such as dizziness, drowsiness, and dizziness. It is important to follow the prescribed dosage and seek medical attention if experiencing serious side effects or changes in mood or behavior. Gabapentin is prescribed by healthcare professionals and should only be taken under medical supervision. I believe there should be a class action lawsuit because they have misrepresented gabapentin. There are many side effects and I have all of them. Furthermore, they do not inform users of the issues if you just stop using gabapentin. Gabapentin Lawsuit 2022 Sign Up. The centralized gabapentin litigation is currently pending in a California federal court. To officially sign up as part of the class action, potential members need to provide their contact information and drug usage history to the law firms appointed as lead counsel. In children aged 5 to 11, the recommended maintenance dosage of Neurontin is 25 mg/kg/day to 35 mg/kg/day, given in three separate doses. Neurontin may be taken as an oral solution, pill, tablet, or combination of these forms. In a long-term clinical investigation, doses of up to 50 mg/kg/day were well tolerated. Learn about the legal process, your rights, and the significance of joining a class action lawsuit for collective strength. Understanding deadlines, staying informed, and being proactive are key Los Angeles, CA: A $325 million preliminary settlement has been reached by Pfizer Inc and Warner-Lambert Co. LLC and plaintiffs who filed a consumer fraud class action lawsuit over the marketing Explore the potential for seeking compensation in gabapentin-related memory loss cases, including legal grounds, evidence, and filing deadlines. Gabapentin, a medication prescribed for nerve pain and seizures, is under scrutiny due to claims of memory loss linked to its use.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | |
![]() | |
![]() | ![]() |
![]() | ![]() |
![]() | |
![]() |